Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

Core Insights - Alector, Inc. is set to host a conference call on February 26, 2025, to discuss its fourth-quarter results for the year ending December 31, 2024, along with a full-year business update [1] - The event will be available via live webcast and will be archived for 30 days for later access [2] Company Overview - Alector is a late-stage clinical biotechnology company focused on developing therapies for neurodegenerative diseases, utilizing genetics, immunology, and neuroscience [3] - The company is advancing a portfolio of programs aimed at removing toxic proteins, replacing deficient proteins, and restoring immune and nerve cell function [3] - Alector's product candidates target various conditions, including frontotemporal dementia, Alzheimer's disease, Parkinson's disease, and Lewy body dementia [3] - The company is developing a proprietary blood-brain barrier platform, Alector Brain Carrier (ABC), to enhance therapeutic delivery and improve patient outcomes [3]